CN106860923A - A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active - Google Patents

A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active Download PDF

Info

Publication number
CN106860923A
CN106860923A CN201710055208.7A CN201710055208A CN106860923A CN 106860923 A CN106860923 A CN 106860923A CN 201710055208 A CN201710055208 A CN 201710055208A CN 106860923 A CN106860923 A CN 106860923A
Authority
CN
China
Prior art keywords
syringe
fat
short
cell
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710055208.7A
Other languages
Chinese (zh)
Inventor
薄滨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Ou Yang Medical Beauty Clinic Co Ltd
Original Assignee
Beijing Ou Yang Medical Beauty Clinic Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Ou Yang Medical Beauty Clinic Co Ltd filed Critical Beijing Ou Yang Medical Beauty Clinic Co Ltd
Priority to CN201710055208.7A priority Critical patent/CN106860923A/en
Publication of CN106860923A publication Critical patent/CN106860923A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/64Containers with integrated suction means
    • A61M1/67Containers incorporating a piston-type member to create suction, e.g. syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3145Filters incorporated in syringes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00792Plastic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1007Breast; mammary
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/35Polyols, e.g. glycerin, inositol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids

Abstract

The present invention proposes a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active, including needle guard, syringe needle and syringe body, the syringe body includes syringe and plunger, the syringe front end is provided with the needle tubing being connected with the syringe needle, the syringe is provided with scale, the screen pack for being fixed on syringe inwall is provided with the syringe, the syringe is provided with cell culture fluid reservoir, there is adipocyte culture liquid in the cell culture fluid reservoir, the cell culture fluid reservoir passes through the first magnetic valve UNICOM with the syringe.The present invention provides the multi-function device that a kind of fat cell is extracted, analyzes and inject one, the environment of the short-term holding fat cell vigor of stabilization can be provided simultaneously, can implement, the once extraction of fat cell, a small amount of multiple injection, the step of repeatedly extracting is reduced, a small amount of multiple injection effect is also improved.

Description

A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active
Technical field
It is more particularly to a kind of short-term to maintain the multi-functional from body fat of fat cell activity the invention belongs to surgical instruments field Fat transplantation device.
Background technology
Autologous fat transplantation art, refers to by the more rich position of human body own fat, such as abdomen, stern, thigh or upper arm etc. Fat, suctioned out with vacuum sliding chute method, by after specially treated or pure lipochondrion, injection implantation needs that what is changed have scarce In Xian Shou areas, to change a kind of operation method improved by area's form.Mostly comparing at present is autologous fat chest enlarge, by body Upper superabundant fats cell transplantation is expelled to chest.Autologous fat transplantation is the lipochondrion of itself, will not also be produced immune anti- Should and rejection, autologous fat transplantation will not cause the change of the endocrinal environment of human body, wound will not be produced in itself to mammary gland Evil, to fertility from now on, lactation, does not have bad influence.Simultaneously autologous fat transplantation materials be easier, to local fat compared with The people for piling up, except doing while face modification, chest enlarge, may also function as weight-reducing, mould perfect concavo-convex body curvature more Effect.
Autologous fat transplantation art, is included in the extraction of negative pressure fat cell, the fat cell of fat cell long position substantially Filtering and require supplementation with fat cell region fat cell inject three steps.It is clear that CN2865698Y discloses a kind of fat Purifier is washed, is made up of with filter dish is crossed Washing cup, can filtered and dispose destroyed fat.The problem of presence is, it is necessary to tight The aseptic environment of lattice could be implemented, and easily pollute external microbe.CN103598901A discloses a kind of fat transplantation device, bag Filter screen, liposuction pipe and fat injection pipe are included, fat, through filter screen filtration, realizes fat after extraction in same device Extract, filtering and fat implantation, it is to avoid cause outside contamination problem in transfer process, the problem for existing is, including can only lean on Fat cell deadweight carries out filtration step, and filter efficiency is low, and the fat cell of partial crushing can not be filtered out effectively, while mistake Filtering velocity degree is slow, influences follow-up injecting step, is also exactly that the fat cell for obtaining can not be preserved, it is necessary to all be expelled to immediately The position that need to be transplanted.In practice, it has been found that during injection in fat cell transplanting, repeatedly a small amount of mode can be more for fat cell Good is moulding, and existing apparatus cannot meet and be actually needed.
The content of the invention
Regarding to the issue above, the present invention proposes a kind of short-term multi-functional autologous fat transplantation for maintaining fat cell active Device, it is possible to achieve the extraction of fat cell, the separation of fat cell and fat cell activity maintaining function, can facilitate, pacify Entirely, multiple a small amount of injection of fat cell is effectively carried out, it is specific as follows:
A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active, including needle guard, syringe needle and injection Device body, the syringe body includes syringe and plunger, and the syringe front end is provided with the needle tubing being connected with the syringe needle, described Syringe is provided with scale, and the screen pack for being fixed on syringe inwall is provided with the syringe, and the fat transplantation device also includes logical The cell culture fluid reservoir that the first magnetic valve is connected with the syringe is crossed, has fat cell in the cell culture fluid reservoir Nutrient solution.
Optionally, the fat transplantation device also includes the cell cleaning fluid connected with the syringe by the second magnetic valve Reservoir, has cell cleaning fluid in the cell cleaning fluid reservoir.
Optionally, the plunger front end is provided with sealing ring.
Optionally, the needle tubing is provided with scale.
Optionally, the syringe is provided with interlayer, and the interlayer is provided with opening.
Optionally, the screen pack is 40-50 mesh.
Optionally, the adipocyte culture liquid be will culture composition and antioxidant to be dissolved in DMEM culture mediums water-soluble Liquid is prepared from, and concentration of the culture composition in the DEME culture medium aqueous solution is 50-200mg/ml, the antioxidant Concentration in the DEME culture medium aqueous solution is 0.1-1.0mg/ml, and the concentration of the DMEM culture mediums aqueous solution is 5- 10mg/mL, the culture composition it is main by following parts by weight into being grouped into:Resveratrol 1-10 parts, the double Huangs of different ginkgo Ketone 0.1-1 parts, hydrolecithin 0.1-1 parts and maltitol 1-5 parts.Optionally, the antioxidant is that ratio of weight and number is 2:1 ascorbyl palmitate and vitamin C.
Optionally, the adipocyte culture liquid also includes energy extender, and the energy extender is in DEME culture mediums Concentration in the aqueous solution is 0.1-1.0 μ g/ml, the energy extender it is main by following parts by weight into being grouped into:It is as follows The each component of parts by weight:Phosphatidyl serine 0.1-1 parts, Sodium Pyruvate 5-8 parts, fumaric acid 1-2 parts, palmitamide 2-8 Part, potassium dihydrogen phosphate 1-5 parts.
Optionally, the cell cleaning fluid is physiological saline.
A kind of embodiment of the invention provides the multi-function device that a kind of fat cell is extracted, analyzes and inject one, this Another embodiment of invention can provide the environment of the short-term holding fat cell vigor of stabilization, it is possible to achieve fat cell Once extract, a small amount of multiple injection, reduce the step of repeatedly extracting, a small amount of multiple injection effect is also improved.
Brief description of the drawings
The syringe body section of structure of Fig. 1 embodiment of the present invention 1;
The syringe body section of structure of Fig. 2 embodiment of the present invention 2;
In figure, 1 syringe, 2 plungers, 3 needle tubings 4, screen pack, 5 cell culture fluid reservoirs, 6 first magnetic valves, 7 cells are clear Washing lotion reservoir, 8 second magnetic valves, 9 sealing rings, 10 interlayers, 11 interlayer openings.
Specific embodiment
Embodiment 1
A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active, as shown in figure 1, a kind of short-term dimension Hold the multi-functional autologous fat transplantation device of fat cell activity, including needle guard, syringe needle and syringe body, the syringe sheet Body includes syringe 1 and plunger 2, and the front end of the syringe 1 is provided with the needle tubing 3 being connected with the syringe needle, and the syringe 1 is provided with quarter The screen pack 4 for being fixed on the inwall of syringe 1 is provided with degree, the syringe 1, the fat transplantation device also includes passing through the first electromagnetism There is fat cell to train in the cell culture fluid reservoir 5 that the UNICOM of valve 6 connects with the syringe 1, the cell culture fluid reservoir 5 Nutrient solution.
Before use, the multi-functional autologous fat transplantation device of the short-term maintenance fat cell activity of the present embodiment needs elder generation Carry out plunger 2 to adjust, its position is located at syringe 1, the first magnetic valve 6 is closed, and pillow is connected on syringe body, Needle guard is enclosed within pillow, is sterilized.After the sterilization of liposuction position is cut, needle guard, needle contact fat cell, along pin are removed Cylinder 1 rearwardly pulls plunger 2, extracts fat cell and enters on the arrival screen pack 4 of syringe 1 by needle tubing 3.Extract fat cell complete Cheng Hou, puts needle guard, opens the first magnetic valve 6, adjustment space position so that adipocyte culture liquid enters in syringe 1, passes through Screen pack 4 is contacted with fat cell, and by suspending repeatedly and filtering adipose cells, the incomplete fat for isolating destruction is thin Born of the same parents.During injection fat cell, adjustment space position so that adipocyte culture liquid enters in cell culture fluid reservoir 5 is closed First magnetic valve 6.Plunger 2 is promoted to head along syringe 1, is promoted fat cell to be reached by needle tubing 3 and syringe needle and is subscribed injection part Position.By the scale on syringe 1, the volume of fat cell, auxiliary can be calculated when extracting fat cell and injection fat cell Extract and injection process completes to judge.The need for for repeatedly a small amount of injection fat cell, can be realized by fractional injection. For the first time after injection fat cell, needle guard is put, open the first magnetic valve 6, adjustment space position so that adipocyte culture liquid Into in syringe 1, contacted with fat cell through screen pack 4, the adipocyte culture liquid environment good for fat cell is provided, Fat cell vigor is improved, extends the fat cell holding time.During to second injection fat cell, adjustment space position makes Obtain adipocyte culture liquid to enter in cell culture fluid reservoir 5, close the first magnetic valve 6.Along syringe 1 plunger is promoted to head 2, promote fat cell to be reached by needle tubing 3 and syringe needle and subscribe injection site.Later multiple injection step is analogized.
The present embodiment is extracted except providing a kind of fat cell, the multi-function device of analysis and injection one, while can be with The environment of the short-term holding fat cell vigor of stabilization is provided, it is possible to implement, the once extraction of fat cell, a small amount of repeatedly note Penetrate, reduce the step of repeatedly extracting, a small amount of multiple injection effect is also improved.
Embodiment 2
Difference with embodiment 1 is that the fat transplantation device also includes passing through the second magnetic valve 8 and the pin The cell cleaning fluid reservoir 7 of the connection of cylinder 1, has cell cleaning fluid in the cell cleaning fluid reservoir 7.The front end of the plunger 2 It is provided with sealing ring 9.The needle tubing 3 is provided with scale.The syringe 1 is provided with interlayer 10, and the interlayer is provided with opening 11.It is described Screen pack 4 is 40-50 mesh.The cell cleaning fluid is physiological saline.
Cell cleaning fluid reservoir and the second magnetic valve 8 in the present embodiment can realize to fat cell inject before it is clear Wash, remove the cell culture fluid in fat cell, it is to avoid subsidiary cell culture fluid is produced to human body during injection fat cell Adverse effect.Before fat cell injection, adjustment space position so that adipocyte culture liquid enters cell culture fluid reservoir 5 It is interior, close the first magnetic valve 6.Then the second magnetic valve 8, adjustment adjustment space position so that physiological saline is fully contacted are opened Fat cell, except the cell culture fluid of attachment removal.Then adjustment space position so that physiological saline enters, into cell cleaning In liquid reservoir 7, the second magnetic valve 8 is closed, then injected.
The front end of the plunger 2 is provided with sealing ring 9, can strengthen the seal of plunger 2 and syringe 1.The needle tubing 3 is provided with Scale, needle tubing 3 is thinner than syringe 1, therefore scale unit on needle tubing 3 is more accurate than scale on syringe 1, can be more accurate it is right Fat cell is quantified.The syringe 1 is provided with interlayer 10, and the interlayer is provided with opening 11, can be added by opening 11 Trash ice creates low temperature environment to interlayer 10, is beneficial to maintain fat cell activity.
Embodiment 3
Difference with embodiment 2 is that the adipocyte culture liquid in cell culture fluid reservoir 5 is will to cultivate group Compound and antioxidant are dissolved in the DMEM culture medium aqueous solution and are prepared from, and culture composition is in the DEME culture medium aqueous solution Concentration is 50mg/ml, and concentration of the antioxidant in the DEME culture medium aqueous solution is 0.1mg/ml, and the DMEM culture mediums are water-soluble The concentration of liquid is 5mg/mL, the culture composition it is main by following parts by weight into being grouped into:1 part of resveratrol, different silver 1 part of 1 part of ginkgetin, 0.1 part of hydrolecithin and maltitol;It is ascorbyl palmitate that the antioxidant is.
Embodiment 4
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 200mg/ Ml, concentration of the antioxidant in the DEME culture medium aqueous solution is 1.0mg/ml, and the concentration of the DMEM culture mediums aqueous solution is 10mg/mL, the culture composition it is main by following parts by weight into being grouped into:10 parts of resveratrol, Isoginkgetin 1 5 parts of part, 0.1 part of hydrolecithin and maltitol;The antioxidant is vitamin C.
Embodiment 5
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ Ml, concentration of the antioxidant in the DEME culture medium aqueous solution is respectively 0.75mg/ml, the concentration of the DMEM culture mediums aqueous solution Be 10mg/mL, the culture composition it is main by following parts by weight into being grouped into:5 parts of resveratrol, Isoginkgetin 1 part of 0.5 part, 0.1 part of hydrolecithin and maltitol;The antioxidant is that ratio of weight and number is 2:1 ascorbic acid palm fibre Glycerin monostearate and ascorbic mixture.
Embodiment 6
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ Ml, concentration of the antioxidant in the DEME culture medium aqueous solution is respectively 0.75mg/ml.The DMEM culture mediums aqueous solution it is dense It is 10mg/mL to spend, the culture composition it is main by following parts by weight into being grouped into:5 parts of resveratrol, different ginkgo are double yellow 1 part of 0.5 part of ketone, 0.1 part of hydrolecithin and maltitol;The antioxidant is that ratio of weight and number is 2:1 ascorbic acid Palmitate and ascorbic mixture;The adipocyte culture liquid also includes energy extender, and the energy extender exists Concentration in the DEME culture medium aqueous solution is 0.1 μ g/ml, and the energy extender is main by following parts by weight into packet Into:0.1 part of phosphatidyl serine, 5 parts of Sodium Pyruvate, 1 part of fumaric acid, 2 parts of palmitamide, 1 part of potassium dihydrogen phosphate.
Embodiment 7
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ The concentration of ml, ascorbyl palmitate and vitamin C in the DEME culture medium aqueous solution is respectively 0.5mg/ml and 0.25mg/ ml.The concentration of the DMEM culture mediums aqueous solution is 10mg/mL, the culture composition it is main by following parts by weight into It is grouped into:1 part of 5 parts of resveratrol, 0.5 part of Isoginkgetin, 0.1 part of hydrolecithin and maltitol;It is described anti-oxidant Agent is that ratio of weight and number is 2:1 ascorbyl palmitate and ascorbic mixture;The adipocyte culture liquid is also wrapped Energy extender is included, concentration of the energy extender in the DEME culture medium aqueous solution is 1.0 μ g/ml, the energy supplement Agent it is main by following parts by weight into being grouped into:1 part of phosphatidyl serine, 8 parts of Sodium Pyruvate, 2 parts of fumaric acid, palmityl 8 parts of amine, 5 parts of potassium dihydrogen phosphate.
Embodiment 8
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ The concentration of ml, ascorbyl palmitate and vitamin C in the DEME culture medium aqueous solution is respectively 0.5mg/ml and 0.25mg/ ml.The concentration of the DMEM culture mediums aqueous solution is 10mg/mL, the culture composition it is main by following parts by weight into It is grouped into:1 part of 5 parts of resveratrol, 0.5 part of Isoginkgetin, 0.1 part of hydrolecithin and maltitol;It is described anti-oxidant Agent is that ratio of weight and number is 2:1 ascorbyl palmitate and ascorbic mixture;The adipocyte culture liquid is also wrapped Energy extender is included, concentration of the energy extender in the DEME culture medium aqueous solution is 0.5 μ g/ml, the energy supplement Agent it is main by following parts by weight into being grouped into:0.5 part of phosphatidyl serine, 5 parts of Sodium Pyruvate, 2 parts of fumaric acid, palm 5 parts of acid amides, 1 part of potassium dihydrogen phosphate.
Reference examples 1
Difference with embodiment 3 is that adipocyte culture liquid is physiological saline.
Reference examples 2
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 50mg/ Ml, concentration of the antioxidant in the DEME culture medium aqueous solution is 0.1mg/ml, and the concentration of the DMEM culture mediums aqueous solution is 5mg/mL, the culture composition it is main by following parts by weight into being grouped into:1 part of resveratrol, Isoginkgetin 1 Part;It is ascorbyl palmitate that the antioxidant is.
Reference examples 3
Difference with embodiment 3 is that concentration of the culture composition in the DEME culture medium aqueous solution is 50mg/ Ml, concentration of the antioxidant in the DEME culture medium aqueous solution is 1.0mg/ml, and the concentration of the DMEM culture mediums aqueous solution is 10mg/mL, concentration of the culture composition in the DEME culture medium aqueous solution is 50mg/ml, and the culture composition is main by such as Lower parts by weight into being grouped into:1 part of Isoginkgetin, 0.1 part of hydrolecithin;It is vitamin C that the antioxidant is.
Reference examples 4
Difference with embodiment 5 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ The concentration of ml, ascorbyl palmitate and vitamin C in the DEME culture medium aqueous solution be respectively 0.5mgl/ml and 0.25mg/ml, the concentration of the DMEM culture mediums aqueous solution is 10mg/mL, and the culture composition is main by following weight Number into being grouped into:1 part of 5 parts of resveratrol, 0.5 part of Isoginkgetin, 0.1 part of hydrolecithin and maltitol;Institute Stating adipocyte culture liquid also includes energy extender, and concentration of the energy extender in the DEME culture medium aqueous solution is 0.1 μ g/ml, the energy extender it is main by following parts by weight into being grouped into:The each component of following parts by weight:Phosphide 0.1 part of acyl serine, 5 parts of Sodium Pyruvate, 1 part of fumaric acid.
Reference examples 5
Difference with embodiment 5 is that concentration of the culture composition in the DEME culture medium aqueous solution is 100mg/ The concentration of ml, ascorbyl palmitate and vitamin C in the DEME culture medium aqueous solution is respectively 0.5mg/ml and 0.25mg/ Ml, the concentration of the DMEM culture mediums aqueous solution is 10mg/mL, the culture composition it is main by following parts by weight into It is grouped into:1 part of 5 parts of resveratrol, 0.5 part of Isoginkgetin, 0.1 part of hydrolecithin and maltitol;The fat is thin Born of the same parents' nutrient solution also includes energy extender, and concentration of the energy extender in the DEME culture medium aqueous solution is 0.1 μ g/ml, The energy extender it is main by following parts by weight into being grouped into:The each component of following parts by weight:2 parts of palmitamide, 1 part of potassium dihydrogen phosphate.
Influence of the cell culture fluid of experimental example 1 to fat cell activity
Filled using the multi-functional autologous fat transplantation of the short-term maintenance fat cell activity of reference examples 1-5 and embodiment 3-8 Put, determined for the ease of cell viability, the filtering function of temporary close device, specifically, covering one layer of PET nucleopore on screen pack Film, the thickness of nucleopore membranes is 8-35um, and nucleopore aperture is 15nm-8um, and cell culture fluid can be passed freely through, fat cell and Fragment cannot pass through.After extracting cell, per 1h cell culture fluid suspension 10min.Suspend every time after terminating, take 1ml fat thin Born of the same parents, cell count is carried out with Countess II FL.Fat cell activity is to preserve the adipocyte count after the regular period to account for The percentage of the adipocyte count of 0h (not preserving directly counting after fat cell extraction).
Influence of the cell culture fluid of table 1 to fat cell activity
As it can be seen from table 1 embodiment 3-5 fat cell activity is significantly better than reference examples 1-3, P<0.05, wherein with reality Example 5 is applied for optimal, is shown suitable culture composition, the DEME culture mediums aqueous solution, antioxidant, can significantly be provided fat cell Vigor, extend storage time;Embodiment 6-8 is significantly better than reference examples 4-5, P<0.05, wherein being optimal, reality with embodiment 8 The implementation method fat cell vigor for applying example 8 still can reach 74% after 72h, show energy extender phosphatidyl serine, Sodium Pyruvate, fumaric acid, palmitamide, potassium dihydrogen phosphate can significantly provide the vigor of fat cell, extend storage time, For the fractional injection of fat cell provides good basis.
Influence of the low temperature environment of the interlayer trash ice of experimental example 2 manufacture to fat cell activity
Trash ice is not added with as control group with the interlayer of embodiment 3, it is experimental group that interlayer is on the rocks.Every group of 5 parallel sampleses.Using The cell viability collection of experimental example 1 and assay method.
Influence of the low temperature environment of the interlayer trash ice of table 2 manufacture to fat cell activity
From table 2 it can be seen that experimental group fat cell activity is significantly better than control group, P<Control group fat after 0.05,12h Cytoactive only has 44%, and control group can reach 74%, shows that the low temperature environment that trash ice interlayer is created can be carried significantly For the vigor of fat cell, further extend storage time.
These are only embodiments of the invention.For a person skilled in the art, it is easy to draped over one's shoulders according to above-mentioned The spirit of dew makes various changes and change to these embodiments.These changes and change are all contained in the application claims Within the scope of restriction.

Claims (10)

1. it is a kind of it is short-term maintain fat cell activity multi-functional autologous fat transplantation device, it is characterised in that including needle guard, pin Head and syringe body, the syringe body include syringe (1) and plunger (2), and syringe (1) front end is provided with and the pin The needle tubing (3) of head connection, the syringe (1) is provided with scale, the syringe (1) and is provided with the mistake for being fixed on syringe (1) inwall Filter screen (4), the fat transplantation device also includes the cell culture fluid connected with the syringe (1) by the first magnetic valve (6) There is adipocyte culture liquid in reservoir (5), the cell culture fluid reservoir (5).
2. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, the fat transplantation device also includes that the cell cleaning fluid connected with the syringe (1) by the second magnetic valve (8) is stored up There is cell cleaning fluid in liquid bath (7), the cell cleaning fluid reservoir (7).
3. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, plunger (2) front end is provided with sealing ring (9).
4. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, the needle tubing (3) is provided with scale.
5. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, the syringe (1) is provided with interlayer (10), the interlayer is provided with opening (11).
6. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, the screen pack (4) is 40-50 mesh.
7. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 1, it is special Levy and be, the adipocyte culture liquid be will culture composition and antioxidant be dissolved in the DMEM culture mediums aqueous solution prepare and Into concentration of the culture composition in the DEME culture medium aqueous solution is 50-200mg/ml, and the antioxidant is trained in DEME It is 0.1-1.0mg/ml to support the concentration in the base aqueous solution, and the concentration of the DMEM culture mediums aqueous solution is 5-10mg/mL, the training Support composition it is main by following parts by weight into being grouped into:Resveratrol 1-10 parts, Isoginkgetin 0.1-1 parts, hydrogenation Lecithin 0.1-1 parts and maltitol 1-5 parts.
8. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 7, it is special Levy and be, the antioxidant is that ratio of weight and number is 2:1 ascorbyl palmitate and ascorbic mixture.
9. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 8, it is special Levy and be, the adipocyte culture liquid also includes energy extender, and the energy extender is in the DEME culture medium aqueous solution Concentration be 0.1-1.0 μ g/ml, the energy extender it is main by following parts by weight into being grouped into:Phosphatidyl serine 0.1-1 parts, Sodium Pyruvate 5-8 parts, fumaric acid 1-2 parts, palmitamide 2-8 parts, potassium dihydrogen phosphate 1-5 parts.
10. a kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell activity as claimed in claim 9, it is special Levy and be, the cell cleaning fluid is physiological saline.
CN201710055208.7A 2017-01-24 2017-01-24 A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active Pending CN106860923A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710055208.7A CN106860923A (en) 2017-01-24 2017-01-24 A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710055208.7A CN106860923A (en) 2017-01-24 2017-01-24 A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active

Publications (1)

Publication Number Publication Date
CN106860923A true CN106860923A (en) 2017-06-20

Family

ID=59157847

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710055208.7A Pending CN106860923A (en) 2017-01-24 2017-01-24 A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active

Country Status (1)

Country Link
CN (1) CN106860923A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108379699A (en) * 2018-04-10 2018-08-10 北京润美玉之光医疗美容门诊部 A kind of fat injection device
CN108940391A (en) * 2018-07-11 2018-12-07 深圳市安思科电子科技有限公司 A kind of fat acquisition bottle with filtering function
CN109364333A (en) * 2018-09-21 2019-02-22 徐州蓝湖信息科技有限公司 Syringe

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681561A (en) * 1995-06-07 1997-10-28 Life Medical Sciences, Inc. Compositions and methods for improving autologous fat grafting
CN1741828A (en) * 2003-01-25 2006-03-01 李喜永 Closed loop fat transplantation system
CN1905916A (en) * 2004-06-23 2007-01-31 Medikan株式会社 Syringe piston using in fat transplantation
CN200987808Y (en) * 2006-04-27 2007-12-12 黄学峰 Auto-fat transplantation adipocyte collecting screening syringe
CN101237821A (en) * 2005-08-12 2008-08-06 奥林巴斯株式会社 Endoscopic therapeutic device, living body tissue analyzing and processing system, and sample-taking method for tissue analysis process
US20090099548A1 (en) * 2006-03-08 2009-04-16 Hyun-Mi Son Device for Regenerating Adipose Tissue and Method for Utilizing Thereof
CN101415451A (en) * 2003-06-18 2009-04-22 马克罗珀尔生物外科公司 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
CN101489605A (en) * 2006-07-11 2009-07-22 Medikan株式会社 Syringe using in fat transplantation
CN102961805A (en) * 2012-06-18 2013-03-13 韶山市夏龙医疗器械制造有限公司 Self-purified fat quantitative transplanting device
CN103598901A (en) * 2013-10-24 2014-02-26 苏雪莲 Fat transplantation device
CN204636431U (en) * 2015-03-26 2015-09-16 华东医院 A kind of fatty filter

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681561A (en) * 1995-06-07 1997-10-28 Life Medical Sciences, Inc. Compositions and methods for improving autologous fat grafting
CN1741828A (en) * 2003-01-25 2006-03-01 李喜永 Closed loop fat transplantation system
CN101415451A (en) * 2003-06-18 2009-04-22 马克罗珀尔生物外科公司 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
CN1905916A (en) * 2004-06-23 2007-01-31 Medikan株式会社 Syringe piston using in fat transplantation
CN101237821A (en) * 2005-08-12 2008-08-06 奥林巴斯株式会社 Endoscopic therapeutic device, living body tissue analyzing and processing system, and sample-taking method for tissue analysis process
US20090099548A1 (en) * 2006-03-08 2009-04-16 Hyun-Mi Son Device for Regenerating Adipose Tissue and Method for Utilizing Thereof
CN200987808Y (en) * 2006-04-27 2007-12-12 黄学峰 Auto-fat transplantation adipocyte collecting screening syringe
CN101489605A (en) * 2006-07-11 2009-07-22 Medikan株式会社 Syringe using in fat transplantation
CN102961805A (en) * 2012-06-18 2013-03-13 韶山市夏龙医疗器械制造有限公司 Self-purified fat quantitative transplanting device
CN103598901A (en) * 2013-10-24 2014-02-26 苏雪莲 Fat transplantation device
CN204636431U (en) * 2015-03-26 2015-09-16 华东医院 A kind of fatty filter

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108379699A (en) * 2018-04-10 2018-08-10 北京润美玉之光医疗美容门诊部 A kind of fat injection device
CN108940391A (en) * 2018-07-11 2018-12-07 深圳市安思科电子科技有限公司 A kind of fat acquisition bottle with filtering function
CN108940391B (en) * 2018-07-11 2020-12-01 临沂文衡信息技术有限公司 Fat collection bottle with filtering capability
CN109364333A (en) * 2018-09-21 2019-02-22 徐州蓝湖信息科技有限公司 Syringe
CN109364333B (en) * 2018-09-21 2023-10-03 徐州蓝湖信息科技有限公司 Injection syringe

Similar Documents

Publication Publication Date Title
US10188777B2 (en) Liposuction device and system and use thereof
CN106860923A (en) A kind of short-term multi-functional autologous fat transplantation device for maintaining fat cell active
JP6072684B2 (en) Cell treatment system and cell treatment apparatus
US8172832B1 (en) Fat harvesting container
CN107174678A (en) A kind of autologous fat collection, purification and transplantation device
CN106754703B (en) A kind of til cell amplification in vitro culture medium combination and cultural method
CN108524601B (en) Vaginal gel containing pleiotropic factors and preparation method thereof
CN105076116A (en) Cell cryopreservation liquid, application thereof and cryopreservation method of megakaryocyte progenitor cells
CN102363749B (en) Preparation method of Phellinus linteus mycelium
CN105462922A (en) Method for increasing yield of immune cells
CN201492455U (en) Device used for extracting, separating and transplanting fat
CN104673751B (en) A kind of efficiently CIK cell cultural method
US20180207331A1 (en) Chamber for the collection of lipoaspirate
CN203999585U (en) A kind of enrichment adipose-derived stem cell automatic extracting device
CN109415675A (en) Use shock wave or the method for mechanical shock separation, dissociation and/or lytic cell
JPWO2019230973A1 (en) Biomaterial Preservation Compositions, Biomaterial Preservation Methods, Biomaterial Production Methods, Transplant Materials, and Transplant Methods
CN103667185A (en) New adipose-derived stem cell technology for plastic surgery and cosmetology
CN107384860A (en) The cultural method of cell culture fluid and NK cells
CN102258810A (en) Preparation method of adipose tissue breast augmentation material enriched with autologous stem cells
CN103860574B (en) Quercitroside is preparing the application in human gamma delta t cells multiplication agent
CN103361311B (en) Method for obtaining leukocytes by using washing disposable leukocyte-removing plastic blood bag
CN203252974U (en) Membrane-filtering type plasma separation cup
CN208087619U (en) A kind of cell collection preservation separating pipe
CN109091404A (en) A kind of compound dragon&#39;s blood facial mask and preparation method thereof with anti-acne U.S. face effect
CN106929472A (en) The preparation method and applications of people&#39;s CD3+CD56+CIK cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination